Debut is the future
We help the pharmaceutical and specialty chemical industries manufacture high value molecules by combining custom designed immobilized enzymes with continuous biomanufacturing processes. Our cell-free platform has the ability to transform low-value bio-renewable materials into high value therapeutics and specialty chemicals.
Combining the power of biocatalysis with continuous manufacturing will create a distinct change in how molecules are created. We believe our novel approaches, mindsets, and technology hold the key for addressing the largest problems in pharmaceutical and specialty chemical manufacturing.
When we look back in ten years it will be hard to remember what traditional chemical manufacturing looked like.
We offer a range of high-value enzymes for biotherapeutic creation and modification.
We create novel immobilization for enzymes with high success rates.
We are committed to transforming how therapeutics and small molecules are made through continuous manufacturing combined with enzymes.
Debut removes the need for extensive R&D. We provide high value immobilized enzymes for use in continuous manufacturing systems.